Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Velcade bortezomib: Additional Phase III data

Additional data from a French Phase III trial in 482 treatment-naïve patients showed that Velcade plus dexamethasone led to a complete and

Read the full 223 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE